Royce & Associates’s Centogene N.V. Common Shares CNTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-200,000
Closed -$2.43M 1054
2021
Q1
$2.43M Hold
200,000
0.02% 727
2020
Q4
$2.16M Hold
200,000
0.02% 707
2020
Q3
$1.89M Buy
+200,000
New +$2.55M 0.02% 685

Other funds holding CNTG

Royce & Associates's CNTG Position: Q2 2021 in Review

Royce & Associates sold out of Centogene N.V. Common Shares (CNTG) in Q2 2021, closing a stake of 200,000 shares — an estimated $2.43M sold.

Royce & Associates first reported a position in CNTG in Q3 2020 and held it in 3 quarters. The position peaked at $2.43M in Q1 2021. 25 funds tracked by Wall St. Rank hold CNTG as of Q2 2021.

  • Royce & Associates reported no remaining Centogene N.V. Common Shares position as of Q2 2021 after selling out during the quarter.
  • Royce & Associates sold 200,000 Centogene N.V. Common Shares shares in Q2 2021, an estimated $2.43M.
  • Royce & Associates first reported a position in Centogene N.V. Common Shares in Q3 2020 and held it in 3 quarters.
  • Royce & Associates's Centogene N.V. Common Shares position peaked at $2.43M in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Centogene N.V. Common Shares as of Q2 2021.

Based on Royce & Associates's 13F filing for Q2 2021, filed 6 Aug 2021.